WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H563947
CAS#: 64924-67-0 (HBr)
Description: Halofuginone Hydrobromide is a potent prolyl-tRNA synthetase inhibitor.
Hodoodo Cat#: H563947
Name: Halofuginone Hydrobromide
CAS#: 64924-67-0 (HBr)
Chemical Formula: C16H18Br2ClN3O3
Exact Mass: 492.94
Molecular Weight: 495.600
Elemental Analysis: C, 38.78; H, 3.66; Br, 32.25; Cl, 7.15; N, 8.48; O, 9.68
Related CAS #: 55837-20-2 (free base) 64924-67-0 (HBr) 1217623-74-9 (HCl) 82186-71-8 (lactate)
Synonym: Halofuginone HBr; Halofuginone-HBr; HalofuginoneHBr; Halofuginone hydrobromide; Halofuginone-hydrobromide; Halofuginonehydrobromide
IUPAC/Chemical Name: (2R*,3S*)-7-Bromo-6-chloro-3-[3-(3-hydroxy-2-piperidinyl)-2-oxopropyl]-4-3H-quinazolinone hydrobromide
InChi Key: SJUWEPZBTXEUMU-LIOBNPLQSA-N
InChi Code: InChI=1S/C16H17BrClN3O3.BrH/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14;/h5-6,8,14-15,19,23H,1-4,7H2;1H/t14-,15+;/m1./s1
SMILES Code: O=C1N(CC(C[C@H]2NCCC[C@@H]2O)=O)C=NC3=C1C=C(Cl)C(Br)=C3.[H]Br
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 495.60 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Zhang J, Yao Q, Liu Z. A Novel Synthesis of the Efficient Anti-Coccidial Drug Halofuginone Hydrobromide. Molecules. 2017 Jun 30;22(7). pii: E1086. doi: 10.3390/molecules22071086. PubMed PMID: 28665346.
2: Zhang DF, Sun BB, Yue YY, Yu HJ, Zhang HL, Zhou QJ, Du AF. Anticoccidial effect of halofuginone hydrobromide against Eimeria tenella with associated histology. Parasitol Res. 2012 Aug;111(2):695-701. doi: 10.1007/s00436-012-2889-7. Epub 2012 Mar 14. PubMed PMID: 22415441.
3: Lista S, Emanuele E. Potential therapeutical effects of topical halofuginone hydrobromide in keloid management. Med Hypotheses. 2007;69(3):707. Epub 2007 Feb 28. PubMed PMID: 17331662.
4: Holland DC, Munns RK, Roybal JE, Hurlbut JA, Long AR. Liquid chromatographic determination of the anticoccidial drug halofuginone hydrobromide in eggs. J AOAC Int. 1995 Jan-Feb;78(1):37-40. PubMed PMID: 7703725.
5: Determination of halofuginone hydrobromide in medicated animal feeds. Analyst. 1983 Oct;108(1291):1252-6. PubMed PMID: 6650842.